Cargando…
High Residual Platelet Reactivity during Aspirin Therapy in Patients with Non-St Segment Elevation Acute Coronary Syndrome: Comparison Between Initial and Late Phases
BACKGROUND: High platelet reactivity (HPR) during therapy with acetylsalicylic acid (ASA) is a poor prognostic factor in acute coronary syndromes (ACS). The prevalence of HPR during ACS is greater than that reported in stable diseases. However, it is unclear whether this prevalence of HPR is a trans...
Autores principales: | Dracoulakis, Marianna Deway Andrade, Gurbel, Paul, Cattaneo, Marco, Martins, Herlon Saraiva, Nicolau, José Carlos, Kalil Filho, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882399/ https://www.ncbi.nlm.nih.gov/pubmed/31432979 http://dx.doi.org/10.5935/abc.20190146 |
Ejemplares similares
-
Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial
por: Vivas, David, et al.
Publicado: (2022) -
Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors
por: Bugiardini, Raffaele, et al.
Publicado: (2020) -
ST-Segment Elevation in Patients with COVID-19: A Late Complication
por: Kaur, Parminder, et al.
Publicado: (2021) -
Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity
por: Pesaro, Antonio Eduardo P., et al.
Publicado: (2012) -
Independent Predictors of Late Presentation in Patients with
ST-Segment Elevation Myocardial Infarction
por: Rodrigues, Juliane Araujo, et al.
Publicado: (2018)